Bilirubin CAS NO.635-65-4
We are a manufacturer based in China. We specialize in providing high-quality Bilirubin CAS NO.635-65-4 for industrial clients across various sectors. Whether you need chemicals consultation or technical support, our team is here to help.
Category：Active Pharmaceutical Ingredients MOQ:100KG Shipped directly from China
Introduction
Catalog ID80017063
CAS NO.635-65-4
Purity 98%
MDL NumberMFCD00005499
EINEC211-239-7
Molecular Formula C33H36N4O6
Molecular Weight 584.6621
| Aspect | Details |
|---|---|
| Definition | Bilirubin is a yellow compound that occurs in the normal catabolic pathway that breaks down heme in red blood cells. |
| Production and Metabolism | – Produced by the breakdown of heme in reticuloendothelial cells, primarily in the spleen.<br>- Conjugated with glucuronic acid in the liver to form water-soluble bilirubin, which is excreted into bile and eventually eliminated through feces or urine. |
| Physiological Functions | – Acts as a potent antioxidant, scavenging reactive oxygen species.<br>- Has immunosuppressive effects and may function as a hormone, influencing various cellular signaling pathways.<br>- Activates the nuclear receptor PPARα, promoting fat burning and reducing adiposity and blood glucose levels. |
| Clinical Significance | – Elevated levels can indicate liver or bile duct problems, or increased red blood cell destruction.<br>- Low levels are associated with conditions like Gilbert’s syndrome, which is characterized by mild hyperbilirubinemia but generally benign.<br>- Moderate increases in bilirubin levels have been linked to reduced risks of metabolic and cardiovascular diseases. |
| Testing and Measurement | – Blood tests measure total bilirubin, direct (conjugated) bilirubin, and indirect (unconjugated) bilirubin.<br>- Used to diagnose jaundice, liver diseases, and monitor the effectiveness of treatments. |
| Potential Therapeutic Uses | – Strategies to increase plasma bilirubin levels are being explored for combating chronic diseases like obesity and diabetes.<br>- Bilirubin nanoparticles are being investigated as potential therapeutic agents for metabolic and cardiovascular diseases |
Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.
20+ years export experience. If you're ready to take the next step or Request Free Samples, Leave your message below and we’ll reply soon.
Inquiry
Factory & Shipment
